Gras S, van Rhijn I, Shahine A, Le Nours J
Cell Mol Life Sci. 2018; 75(9):1623-1639.
PMID: 29340708
PMC: 6328055.
DOI: 10.1007/s00018-018-2749-4.
Pellicci D, Uldrich A, Le Nours J, Ross F, Chabrol E, Eckle S
J Exp Med. 2014; 211(13):2599-615.
PMID: 25452463
PMC: 4267242.
DOI: 10.1084/jem.20141764.
Teo W, Elghetany M, Shen J, Man T, Li X, Chintagumpala M
J Neurooncol. 2014; 120(2):293-301.
PMID: 25115738
DOI: 10.1007/s11060-014-1572-5.
Nowak M, Schmidt-Wolf I
Cancers (Basel). 2013; 3(3):3661-75.
PMID: 24212972
PMC: 3759215.
DOI: 10.3390/cancers3033661.
Uldrich A, Le Nours J, Pellicci D, Gherardin N, McPherson K, Lim R
Nat Immunol. 2013; 14(11):1137-45.
PMID: 24076636
DOI: 10.1038/ni.2713.
Recognition of CD1d-restricted antigens by natural killer T cells.
Rossjohn J, Pellicci D, Patel O, Gapin L, Godfrey D
Nat Rev Immunol. 2012; 12(12):845-57.
PMID: 23154222
PMC: 3740582.
DOI: 10.1038/nri3328.
The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.
Peng Y, Zhao L, Shekhar S, Liu L, Wang H, Chen Q
Cell Mol Immunol. 2012; 9(4):361-6.
PMID: 22728762
PMC: 4012869.
DOI: 10.1038/cmi.2012.19.
SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.
Detre C, Keszei M, Romero X, Tsokos G, Terhorst C
Semin Immunopathol. 2010; 32(2):157-71.
PMID: 20146065
PMC: 2868096.
DOI: 10.1007/s00281-009-0193-0.
The A2aR adenosine receptor controls cytokine production in iNKT cells.
Nowak M, Lynch L, Yue S, Ohta A, Sitkovsky M, Balk S
Eur J Immunol. 2009; 40(3):682-7.
PMID: 20039304
PMC: 2967447.
DOI: 10.1002/eji.200939897.
Invariant TCR rather than CD1d shapes the preferential activities of C-glycoside analogues against human versus murine invariant NKT cells.
Li X, Shiratsuchi T, Chen G, Dellabona P, Casorati G, Franck R
J Immunol. 2009; 183(7):4415-21.
PMID: 19734232
PMC: 3603359.
DOI: 10.4049/jimmunol.0901021.
Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.
Pellicci D, Patel O, Kjer-Nielsen L, Pang S, Sullivan L, Kyparissoudis K
Immunity. 2009; 31(1):47-59.
PMID: 19592275
PMC: 2765864.
DOI: 10.1016/j.immuni.2009.04.018.
T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire.
Mallevaey T, Scott-Browne J, Matsuda J, Young M, Pellicci D, Patel O
Immunity. 2009; 31(1):60-71.
PMID: 19592274
PMC: 2965025.
DOI: 10.1016/j.immuni.2009.05.010.
A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun K, Borg N, Kjer-Nielsen L, Beddoe T, Koh R, Richardson S
J Exp Med. 2008; 205(4):939-49.
PMID: 18378792
PMC: 2292230.
DOI: 10.1084/jem.20072141.
A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition.
Kjer-Nielsen L, Borg N, Pellicci D, Beddoe T, Kostenko L, Clements C
J Exp Med. 2006; 203(3):661-73.
PMID: 16505140
PMC: 2118261.
DOI: 10.1084/jem.20051777.
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.
Zajonc D, Maricic I, Wu D, Halder R, Roy K, Wong C
J Exp Med. 2005; 202(11):1517-26.
PMID: 16314439
PMC: 2213337.
DOI: 10.1084/jem.20051625.
